Delivery Order SPE2DB24D1034-SPE2DB25FWDD7

Award Date 5/22/25
Potential Completion Date 5/23/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, with a ceiling value of $1,122.53 and a period of performance through May 14, 2025. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, with a ceiling value of $5,955.31 and a performance period through May 23, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, with a ceiling value of $1,022.80 and a completion date of May 22, 2025. The contract is a firm fixed-price arrangement and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,258.60 firm fixed-price contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. The delivery order has a period of performance through May 16, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. The contract has a ceiling value of $1,721.76 and is a firm fixed price delivery order with a period of performance through May 22, 2025. The contract is not set aside and is therefore open to full and open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, with a ceiling value of $1,160.08. The contract is a firm fixed price, non-set-aside delivery order that has an ultimate completion date of May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4568347048 LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. The contract has a firm fixed price of $1,475.99 and a ceiling value of $1,475.99, with an ultimate completion date of May 27, 2025. This award is not set aside for any particular business category....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus SoloStar 100 unit/mL 3mL, with a ceiling value of $1,002.84 and a completion date of May 13, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lantus SoloStar 100 unit/mL 3mL, a diabetes medication, with a ceiling value of $1,425.76 and a period of performance through May 5, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,781.59, is for the procurement of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used in the treatment of diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of January 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB25FWDD7
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, with a ceiling value of $1,239.85 and a period of performance through May 23, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. This delivery order is likely part of that larger IDC, demonstrating Amerisourcebergen's role as a critical vendor in supporting federal medical procurement needs, particularly for the Defense Health Agency, U.S. Coast Guard, and other government agencies.

Generated 8/24/25, 1:00 AM